{"entity":{"id":"nct04752826","kind":"trial","name":"BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)","aka":[],"tldr":"A phase 1/2 trial of Pembrolizumab in ovarian cancer and melanoma, run by BioInvent International AB, now recruiting.","summary":"BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) is a phase 1/2 interventional study registered as NCT04752826 by BioInvent International AB, with 176 participants planned, started 2021-01-25 and due to reach its primary completion in 2026-12-31. Interventions recorded: BI-1808, Pembrolizumab (KEYTRUDA® ) 25 Mg/mL Solution for Injection. Conditions listed: Advanced Malignancies, Ovarian Cancer, T-cell Lymphoma, Melanoma. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT04752826","url":"https://clinicaltrials.gov/study/NCT04752826"}],"tags":["ctgov-ingest"],"related":[],"cancers":["ovarian","melanoma"],"sections":[],"technologies":[],"targets":[],"drugs":["pembrolizumab"],"companies":["bioinvent-international"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT04752826","phase":"1/2","setting":"Phase 1/2a Open-Label, Dose-Escalation, Multicenter, FIH, Consecutive-Cohort, Clinical Trial of BI-1808, a Monoclonal Antibody to TNFR 2 as a Single Agent and in Combination With Pembrolizumab (MK-3475-D20) in Subjects With Advanced Malignancies","sponsor":"BioInvent International AB","enrolled":176,"outcomes":[]},"route":"/trials/nct04752826/","neighbours":{"cancer":[{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"}],"drug":[{"id":"pembrolizumab","kind":"drug","name":"Pembrolizumab","route":"/drugs/pembrolizumab/"}],"company":[{"id":"bioinvent-international","kind":"company","name":"BioInvent International","route":"/companies/bioinvent-international/"}]}}